Corteva (NYSE:CTVA) Given New $11.00 Price Target at Royal Bank Of Canada

Corteva (NYSE:CTVA) had its target price decreased by analysts at Royal Bank Of Canada from $17.00 to $11.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price objective would suggest a potential upside of 18.06% from the company’s previous close.

A number of other brokerages have also recently weighed in on CTVA. Morgan Stanley restated an “overweight” rating and issued a $18.00 price objective on shares of Corteva in a research note on Friday, October 2nd. JPMorgan Chase & Co. upgraded Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price objective for the company in a research report on Tuesday, October 6th. Mizuho set a $16.00 price objective on shares of Corteva in a report on Thursday. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, BMO Capital Markets set a $15.00 target price on Corteva in a research report on Friday, October 2nd. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $56.64.

Corteva Trading Up 1.4%

Corteva stock traded up $0.13 during midday trading on Friday, reaching $9.32. The stock had a trading volume of 5,173,987 shares, compared to its average volume of 8,271,338. The firm’s fifty day simple moving average is $38.81 and its two-hundred day simple moving average is $69.88. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva has a twelve month low of $9.01 and a twelve month high of $90.97. The firm has a market cap of $6.22 billion, a price-to-earnings ratio of 6.19, a PEG ratio of 1.69 and a beta of 0.58.

Hedge Funds Weigh In On Corteva

A number of hedge funds have recently bought and sold shares of CTVA. Xcelsior Advisor Partners LLC lifted its position in Corteva by 26.6% in the 3rd quarter. Xcelsior Advisor Partners LLC now owns 24,281 shares of the company’s stock valued at $1,885,000 after acquiring an additional 5,107 shares in the last quarter. Bleakley Financial Group LLC grew its stake in shares of Corteva by 12.5% in the 3rd quarter. Bleakley Financial Group LLC now owns 18,309 shares of the company’s stock worth $1,422,000 after acquiring an additional 2,032 shares in the last quarter. N.F.U. MUTUAL UNIT MANAGERS Ltd bought a new stake in shares of Corteva in the 3rd quarter worth $1,325,000. Gabelli Funds LLC raised its holdings in shares of Corteva by 32.9% in the third quarter. Gabelli Funds LLC now owns 46,500 shares of the company’s stock valued at $3,611,000 after purchasing an additional 11,500 shares during the last quarter. Finally, Advisors Asset Management Inc. bought a new position in shares of Corteva during the third quarter valued at about $2,856,000. Institutional investors own 81.54% of the company’s stock.

Recent Corteva Headlines

Investors following CTVA have been watching these headlines:

• Positive Sentiment: Corteva said strong growth in new-product sales and operational execution helped cushion market headwinds. Reported adjusted third-quarter EPS of $0.06 also topped FactSet’s $0.02 estimate, though other measures of the quarter and the outlook disappointed investors. Corteva third-quarter results and outlook
• Negative Sentiment: Management lowered its 2026 adjusted EPS guidance to $0.76–$0.80, below the roughly $1.07 analyst consensus. The company cited weaker-than-expected Brazilian market conditions; its CEO warned that the slump could continue to weigh on results. Reuters report on Brazil weakness and forecast cut
• Negative Sentiment: A law firm announced an investigation into possible securities-law violations following the stock’s steep decline. The announcement is a potential legal overhang, but it is an investigation—not a finding of wrongdoing. Securities investigation announcement

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.